Why the study?
Does i.v. procainamide alter electrophysiological properties and prevent induction of PSVT in patients with dual pathway A-V nodal re-entrant tachycardia?
Does i.v. procainamide alter electrophysiological properties and prevent induction of PSVT in patients with dual pathway A-V nodal re-entrant tachycardia?
Intravenous procainamide effectively depresses retrograde fast pathway conduction and prevents the induction of sustained PSVT in patients with AV nodal re-entrant tachycardia.
Answers are grounded in this paper and cite their sources.
i.v. procainamide may suppress AVNRT inducibility acutely; hypothesis-generating and should not yet change practice.
Electrophysiological effects of 750 mg i.v.procain- amide were studied in 14 patients with dual pathway atrioventricular (A-V) nodal re-entrant paroxysmal tachycardia (PSVT).All patients utilized an A-V nodal slow pathway for antegrade and an A-V nodal fast pathway for retrograde conduction during PSVT.In all 14 patients, procainamide depressed retrograde fast pathway con- duction, manifest by increase in mean ± SEM ventricular paced cycle length (CL) producing V-A block from 5 295 ± 25 to 385 ± 17 msec (P < 0.001).Antegrade fast and slow pathway properties were unchanged with procainamide.Eleven of the 14 patients had induction of sustained PSVT before procainamide.
No takes yet. Share an insight, caveat, or question.
Wu et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: